{"nctId":"NCT01390077","briefTitle":"Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria","startDateStruct":{"date":"2011-01"},"conditions":["Alkaptonuria"],"count":8,"armGroups":[{"label":"Nitisinone","type":"EXPERIMENTAL","interventionNames":["Drug: Nitisinone"]}],"interventions":[{"name":"Nitisinone","otherNames":["OrfadinÂ®,","NTBC"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Diagnosis of alkaptonuria with documented increased excretion of homogentisic acid\n2. Willing and able to provide written, signed informed consent, or age appropriate written assent and written informed consent by a legally authorized representative after the study has been explained, prior to any research-related procedures.\n3. Willing and able to be seen in the UCSD Clinical Center for Research or a satellite site for the study visits\n4. Possession of insurance coverage for standard of care procedures, clearly stated in the consent forms\n\nExclusion Criteria:\n\n1. Baseline tyrosine level above 250 mmol/mL\n2. Baseline serum creatinine, creatine kinase, or transaminases 2x upper limit of normal\n3. Baseline anemia or thrombocytopenia\n4. Current participation in another investigational medication trial.\n5. Pregnant or lactating women\n6. Current keratopathy, contact use or uncontrolled glaucoma\n7. History myocardial infarction or arrhythmia\n8. History of pulmonary insufficiency\n9. Psychiatric illness that may interfere with compliance or communication\n10. Current malignancy or hypertension","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Homogentisic Acid Excretion","description":"Urine homogentisic acid (umol/mmol creatinine)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1425.9","spread":"678.3"},{"groupId":"OG001","value":"113.1","spread":"70.9"},{"groupId":"OG002","value":"34.0","spread":"12.9"}]}]}]},{"type":"SECONDARY","title":"Tyrosine Levels","description":"Plasma tyrosine (uM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.1","spread":"14.8"},{"groupId":"OG001","value":"668.7","spread":"114.7"},{"groupId":"OG002","value":"703.7","spread":"120.8"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":["Ocular irritation","Abdominal discomfort"]}}}